Cognitive-behavioral therapy for PANDAS-related obsessive-compulsive disorder

Findings from a preliminary waitlist controlled open trial

Eric A. Storch, Tanya K. Murphy, Gary R. Geffken, Giselle Mann, Jennifer Adkins, Lisa J. Merlo, Danny Duke, Melissa Munson, Zoe Swaine, Wayne K. Goodman

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

OBJECTIVE: To provide preliminary estimates of the effectiveness of cognitive-behavioral therapy (CBT) in treating pediatric obsessive-compulsive disorder (OCD) of the pediatric autoimmune neuropsychiatric disorders associated with streptococcus (PANDAS) subtype. METHOD: Seven children with OCD of the PANDAS subtype (range 9-13 years) were treated in a 3-week intensive CBT program conducted at a university clinic. Six of seven children were taking selective serotonin reuptake inhibitor medication(s) upon presentation. Assessments were conducted at four time points: baseline, pretreatment approximately 4 weeks later, posttreatment, and 3-month follow-up. Raters were blind to the nature of the study treatment. RESULTS: Six of seven participants were classified as treatment responders (much or very much improved) at posttreatment, and three of six remained responders at follow-up. Clinician severity ratings, as measured by the Children's Yale-Brown Obsessive-Compulsive Scale and Anxiety Disorder Interview Schedule for DSM-IV Child Interview Schedule-Parent version, decreased significantly following intervention, with effect sizes of 3.38 and 2.29, respectively. Self-reported general anxiety and depression symptoms were not significantly reduced. CONCLUSIONS: This study provides preliminary support for CBT in treating the PANDAS subtype of pediatric OCD. This approach is also considered a safe and minimally invasive treatment approach.

Original languageEnglish (US)
Pages (from-to)1171-1178
Number of pages8
JournalJournal of the American Academy of Child and Adolescent Psychiatry
Volume45
Issue number10
DOIs
StatePublished - Oct 2006
Externally publishedYes

Fingerprint

Obsessive-Compulsive Disorder
Cognitive Therapy
Streptococcus
Pediatrics
Appointments and Schedules
Interviews
Serotonin Uptake Inhibitors
Anxiety Disorders
Diagnostic and Statistical Manual of Mental Disorders
Therapeutics
Anxiety
Depression

Keywords

  • Cognitive-behavioral therapy
  • Obsessive-compulsive disorder
  • Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Developmental and Educational Psychology

Cite this

Cognitive-behavioral therapy for PANDAS-related obsessive-compulsive disorder : Findings from a preliminary waitlist controlled open trial. / Storch, Eric A.; Murphy, Tanya K.; Geffken, Gary R.; Mann, Giselle; Adkins, Jennifer; J. Merlo, Lisa; Duke, Danny; Munson, Melissa; Swaine, Zoe; Goodman, Wayne K.

In: Journal of the American Academy of Child and Adolescent Psychiatry, Vol. 45, No. 10, 10.2006, p. 1171-1178.

Research output: Contribution to journalArticle

Storch, Eric A. ; Murphy, Tanya K. ; Geffken, Gary R. ; Mann, Giselle ; Adkins, Jennifer ; J. Merlo, Lisa ; Duke, Danny ; Munson, Melissa ; Swaine, Zoe ; Goodman, Wayne K. / Cognitive-behavioral therapy for PANDAS-related obsessive-compulsive disorder : Findings from a preliminary waitlist controlled open trial. In: Journal of the American Academy of Child and Adolescent Psychiatry. 2006 ; Vol. 45, No. 10. pp. 1171-1178.
@article{c37523e1db784d2d9dffb413a0be5eb4,
title = "Cognitive-behavioral therapy for PANDAS-related obsessive-compulsive disorder: Findings from a preliminary waitlist controlled open trial",
abstract = "OBJECTIVE: To provide preliminary estimates of the effectiveness of cognitive-behavioral therapy (CBT) in treating pediatric obsessive-compulsive disorder (OCD) of the pediatric autoimmune neuropsychiatric disorders associated with streptococcus (PANDAS) subtype. METHOD: Seven children with OCD of the PANDAS subtype (range 9-13 years) were treated in a 3-week intensive CBT program conducted at a university clinic. Six of seven children were taking selective serotonin reuptake inhibitor medication(s) upon presentation. Assessments were conducted at four time points: baseline, pretreatment approximately 4 weeks later, posttreatment, and 3-month follow-up. Raters were blind to the nature of the study treatment. RESULTS: Six of seven participants were classified as treatment responders (much or very much improved) at posttreatment, and three of six remained responders at follow-up. Clinician severity ratings, as measured by the Children's Yale-Brown Obsessive-Compulsive Scale and Anxiety Disorder Interview Schedule for DSM-IV Child Interview Schedule-Parent version, decreased significantly following intervention, with effect sizes of 3.38 and 2.29, respectively. Self-reported general anxiety and depression symptoms were not significantly reduced. CONCLUSIONS: This study provides preliminary support for CBT in treating the PANDAS subtype of pediatric OCD. This approach is also considered a safe and minimally invasive treatment approach.",
keywords = "Cognitive-behavioral therapy, Obsessive-compulsive disorder, Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections",
author = "Storch, {Eric A.} and Murphy, {Tanya K.} and Geffken, {Gary R.} and Giselle Mann and Jennifer Adkins and {J. Merlo}, Lisa and Danny Duke and Melissa Munson and Zoe Swaine and Goodman, {Wayne K.}",
year = "2006",
month = "10",
doi = "10.1097/01.chi.0000231973.43966.a0",
language = "English (US)",
volume = "45",
pages = "1171--1178",
journal = "Journal of the American Academy of Child and Adolescent Psychiatry",
issn = "0890-8567",
publisher = "Elsevier Limited",
number = "10",

}

TY - JOUR

T1 - Cognitive-behavioral therapy for PANDAS-related obsessive-compulsive disorder

T2 - Findings from a preliminary waitlist controlled open trial

AU - Storch, Eric A.

AU - Murphy, Tanya K.

AU - Geffken, Gary R.

AU - Mann, Giselle

AU - Adkins, Jennifer

AU - J. Merlo, Lisa

AU - Duke, Danny

AU - Munson, Melissa

AU - Swaine, Zoe

AU - Goodman, Wayne K.

PY - 2006/10

Y1 - 2006/10

N2 - OBJECTIVE: To provide preliminary estimates of the effectiveness of cognitive-behavioral therapy (CBT) in treating pediatric obsessive-compulsive disorder (OCD) of the pediatric autoimmune neuropsychiatric disorders associated with streptococcus (PANDAS) subtype. METHOD: Seven children with OCD of the PANDAS subtype (range 9-13 years) were treated in a 3-week intensive CBT program conducted at a university clinic. Six of seven children were taking selective serotonin reuptake inhibitor medication(s) upon presentation. Assessments were conducted at four time points: baseline, pretreatment approximately 4 weeks later, posttreatment, and 3-month follow-up. Raters were blind to the nature of the study treatment. RESULTS: Six of seven participants were classified as treatment responders (much or very much improved) at posttreatment, and three of six remained responders at follow-up. Clinician severity ratings, as measured by the Children's Yale-Brown Obsessive-Compulsive Scale and Anxiety Disorder Interview Schedule for DSM-IV Child Interview Schedule-Parent version, decreased significantly following intervention, with effect sizes of 3.38 and 2.29, respectively. Self-reported general anxiety and depression symptoms were not significantly reduced. CONCLUSIONS: This study provides preliminary support for CBT in treating the PANDAS subtype of pediatric OCD. This approach is also considered a safe and minimally invasive treatment approach.

AB - OBJECTIVE: To provide preliminary estimates of the effectiveness of cognitive-behavioral therapy (CBT) in treating pediatric obsessive-compulsive disorder (OCD) of the pediatric autoimmune neuropsychiatric disorders associated with streptococcus (PANDAS) subtype. METHOD: Seven children with OCD of the PANDAS subtype (range 9-13 years) were treated in a 3-week intensive CBT program conducted at a university clinic. Six of seven children were taking selective serotonin reuptake inhibitor medication(s) upon presentation. Assessments were conducted at four time points: baseline, pretreatment approximately 4 weeks later, posttreatment, and 3-month follow-up. Raters were blind to the nature of the study treatment. RESULTS: Six of seven participants were classified as treatment responders (much or very much improved) at posttreatment, and three of six remained responders at follow-up. Clinician severity ratings, as measured by the Children's Yale-Brown Obsessive-Compulsive Scale and Anxiety Disorder Interview Schedule for DSM-IV Child Interview Schedule-Parent version, decreased significantly following intervention, with effect sizes of 3.38 and 2.29, respectively. Self-reported general anxiety and depression symptoms were not significantly reduced. CONCLUSIONS: This study provides preliminary support for CBT in treating the PANDAS subtype of pediatric OCD. This approach is also considered a safe and minimally invasive treatment approach.

KW - Cognitive-behavioral therapy

KW - Obsessive-compulsive disorder

KW - Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections

UR - http://www.scopus.com/inward/record.url?scp=33749053229&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749053229&partnerID=8YFLogxK

U2 - 10.1097/01.chi.0000231973.43966.a0

DO - 10.1097/01.chi.0000231973.43966.a0

M3 - Article

VL - 45

SP - 1171

EP - 1178

JO - Journal of the American Academy of Child and Adolescent Psychiatry

JF - Journal of the American Academy of Child and Adolescent Psychiatry

SN - 0890-8567

IS - 10

ER -